XIN YUAN ENT(01748) received additional resumption guidance.

19:47 18/03/2026

Xinyuan Enterprise Group (01748) announced that following the resumption guidance provided by the Stock Exchange on May 29, 2025 as stated in the announcement provided to the company, the company received a letter from the Stock Exchange on May 17, 2026. Based on this, the Stock Exchange has imposed additional resumption guidance on the resumption of trading of shares, together with the initial resumption guidance collectively referred to.

XIN YUAN ENT (01748) issued an announcement that, following the resumption guidance provided by the Stock Exchange on May 29, 2025, the company received a letter from the Stock Exchange on May 17, 2026. Accordingly, the Stock Exchange has imposed additional resumption guidance on the resumption of trading in shares, together with the initial resumption guidance. In addition, the trading suspension continues.

EAST BUY (01797) issued a total of 5.4697 million shares under the stock incentive plan.

Pfizer Inc. (PFE.US) achieves primary endpoint with potential "first-in-class" small molecule combination therapy.

FIRST SERVICE (02107) is expected to incur a net loss of no more than 53 million yuan for the year.

EAST BUY (01797) issued a total of 5.4697 million shares under the stock incentive plan.

Pfizer Inc. (PFE.US) achieves primary endpoint with potential "first-in-class" small molecule combination therapy.

FIRST SERVICE (02107) is expected to incur a net loss of no more than 53 million yuan for the year.